Natural Alternatives International AI Stock Analysis
Want to see NAII full AI Analyst Report?
Natural Alternatives International (NAII) AI Stock Analysis
Natural Alternatives International
(NASDAQ:NAII)
Weak financial performance from collapsing margins and losses is the dominant factor weighing on the score, with bearish technicals adding pressure despite oversold signals; poor valuation offers little support.
Natural Alternatives International Key Performance Indicators (KPIs)
Revenue by SegmentShows how much each business segment contributes to overall sales, indicating which areas drive growth and where diversification or expansion opportunities may exist.
Private Label Contract Manufacturing remains NAII’s revenue engine — it swung from a 2023 trough into a steady partial rebound through 2024–Q1 2026 but hasn’t regained the 2020–2022 highs, suggesting demand normalization rather than a step-change expansion; investors should watch if gains are durable (new contracts vs. restocking/seasonality) and whether margins improve. Patent and Trademark Licensing is a small, volatile tail revenue stream with no clear growth trajectory, so near-term upside depends on scaling contract-manufacturing volume and customer diversification.
The FlyNatural Alternatives International (NAII) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $6.06M
- Dividend Yield
- ―
- Average Volume (3M)
- 21.63K
- Price to Earnings (P/E)
- -0.3
- Beta (1Y)
- 0.21
- Revenue Growth
- 9.08%
- EPS Growth
- -52.59%
- Country
- US
- Employees
- 301
- Sector
- Consumer Defensive
- Sector Strength
- 62
- Industry
- Packaged Foods
Natural Alternatives International Business Overview & Revenue Model
Company Description
Natural Alternatives International, Inc. (NAII) is a company dedicated to the global development, manufacturing, and marketing of nutritional supplements, with operations spanning the United States, Europe, Asia, and other international territories....
Natural Alternatives International Financial Statement Overview
Summary
Severe margin collapse with gross margins at 4.4% and TTM net margin of -17.2%, eroding equity to 47.2M and inconsistent cash flows limit long-term viability.
Income Statement
22NegativeBalance Sheet
38NegativeCash Flow
33Negative| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 132.91M | 142.51M | 129.86M | 113.80M | 154.01M | 170.97M |
| Gross Profit | 5.87M | 9.00M | 9.29M | 6.87M | 18.16M | 30.51M |
| EBITDA | -18.14M | -14.37M | -2.70M | -4.46M | 8.26M | 17.91M |
| Net Income | -22.88M | -20.70M | -13.57M | -7.22M | 2.52M | 10.71M |
Balance Sheet | ||||||
| Total Assets | 114.53M | 126.45M | 151.94M | 162.34M | 134.15M | 146.00M |
| Cash, Cash Equivalents and Short-Term Investments | 6.49M | 7.39M | 12.32M | 11.98M | 13.60M | 21.83M |
| Total Debt | 30.47M | 49.97M | 59.03M | 60.29M | 30.93M | 31.84M |
| Total Liabilities | 67.34M | 76.49M | 83.51M | 79.75M | 45.38M | 57.48M |
| Stockholders Equity | 47.19M | 49.96M | 68.43M | 82.59M | 88.77M | 88.52M |
Cash Flow | ||||||
| Free Cash Flow | 311.00K | -12.62M | 2.32M | -4.51M | -6.50M | -14.62M |
| Operating Cash Flow | 3.67M | -8.92M | 5.93M | -1.50M | 7.02M | 11.87M |
| Investing Cash Flow | -2.94M | -3.70M | -3.61M | -3.02M | -13.47M | -26.46M |
| Financing Cash Flow | 5.63M | 7.77M | -1.97M | 2.89M | -1.78M | 4.29M |
Natural Alternatives International Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NAII, the sentiment is Negative. The current price of 0.97 is below the 20-day moving average (MA) of 1.10, below the 50-day MA of 1.41, and below the 200-day MA of 2.29, indicating a bearish trend. The MACD of -0.11 indicates Negative momentum. The RSI at 30.35 is Neutral, neither overbought nor oversold. The STOCH value of 19.43 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for NAII.
Natural Alternatives International Risk Analysis
Natural Alternatives International disclosed 22 risk factors in its most recent earnings report. Natural Alternatives International reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
3 New RisksNatural Alternatives International Peers Comparison
Overall Rating
FTLF63Neutral
LFVN54Neutral
NATR53Neutral
USNA52Neutral
HAIN41Neutral- NAII41Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| FTLF | 63Neutral | $77.95M | 12.85 | 13.98% | ― | 60.61% | -22.94% |
| Sector * | 62Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
| LFVN | 54Neutral | $63.92M | 23.19 | 8.17% | 3.82% | -24.79% | -73.68% |
| NATR | 53Neutral | $178.14M | 12.48 | 8.76% | ― | 1.21% | 0.20% |
| USNA | 52Neutral | $235.21M | -11.54 | -3.98% | ― | -0.78% | -228.47% |
| HAIN | 41Neutral | $13.00M | -0.04 | -140.07% | ― | -18.74% | 45.19% |
| NAII | 41Neutral | $5.96M | -0.26 | -33.23% | ― | 9.08% | -52.59% |
* Consumer Defensive Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| NAII | Natural Alternatives International | 0.97 | -1.99 | -67.36% | |
| NATR | Nature's Sunshine Products | 10.36 | -10.17 | -49.54% | |
| HAIN | The Hain Celestial | 0.14 | -1.12 | -88.89% | |
| USNA | USANA Health Sciences Inc | 13.24 | -5.68 | -30.02% | |
| LFVN | LifeVantage Corp | 4.97 | -1.13 | -18.52% | |
| FTLF | Fitlife Brands | 8.48 | -9.12 | -51.82% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 14, 2026